Cited by 336Rheumatoid Arthritis Research and TherapiesAutoimmune and Inflammatory Disorders ResearchOsteoarthritis Treatment and Mechanisms

Synovial membrane cytokine expression is predictive of joint damage progression in rheumatoid arthritis: A two‐year prospective study (the DAMAGE study cohort)

Kirkham, Bruce W., Lassere, Marissa N., Edmonds, John P., Juhasz, Katherine M., Bird, Paul A., Lee, C. Soon, Shnier, Ron, Portek, Ian J.·2006·Arthritis & Rheumatism

Abstract

Objective: The primary aim of this prospective 2‐year study was to explain the wide variability in joint damage progression in patients with rheumatoid arthritis (RA) from measures of pathologic changes in the synovial membrane. Methods: Patients underwent clinical measurements and joint damage assessments by magnetic resonance imaging (MRI) and radiography at enrollment and at year 2. Synovial membrane was obtained by knee biopsy and assessed histologically by hematoxylin and eosin staining. Interleukin‐1β (IL‐1β), IL‐10, IL‐16, IL‐17, RANKL, tumor necrosis factor α (TNFα), and interferon‐γ (IFNγ) messenger RNA (mRNA) expression was determined by quantitative reverse transcription–polymerase chain reaction. The relationship of synovial measurements to joint damage progression was determined by multivariate analysis. Results: Sixty patients were enrolled. Histologic features had no relationship to damage progression. Multivariate analysis by several different methods consistently demonstrated that synovial membrane mRNA levels of IL‐1β, TNFα, IL‐17, and IL‐10 were predictive of damage progression. IL‐17 was synergistic with TNFα. TNFα and IL‐17 effects were most pronounced with shorter disease duration, and IL‐1β effects were most pronounced with longer disease duration. IFNγ was protective. These factors explained 57% of the MRI joint damage progression over 2 years. Conclusion: We have demonstrated for the first time in a prospective study that synovial membrane cytokine mRNA expression is predictive of joint damage progression in RA. The findings for IL‐1β and TNFα are consistent with results of previous clinical research, but the protective role of IFNγ, the differing effects of disease duration, and IL‐17–cytokine interactions had only been demonstrated previously by animal and in vitro research. These findings explain some of the variability of joint damage in RA and identify new targets for therapy.

Integrity signals

Registry

Crossref · 10.1002/art.21749

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Transfer of in vitro differentiated pathogenic Th17 cells expressing a MOG35-55-specific transgenic TCR is sufficient to induce severe disease in recipient mice.

    “the transfer of in vitro differentiated pathogenic Th17 cells expressing a transgenic TCR specific for the MOG35–55 peptide (2D2 cells [114]) is sufficient to induce severe disease in recipient mice”

    From TH17 cell heterogeneity and its role in tissue inflammation (2023) · cites this paper as [115]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Kirkham, B. W., Lassere, M. N., Edmonds, J. P., Juhasz, K. M., Bird, P. A., Lee, C. S., Shnier, R., & Portek, I. J.
Affiliations
  • Guy's Hospital (GB)
  • St George Hospital (AU)
  • Royal Prince Alfred Hospital (AU)
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
2006-03-29
Volume
54
Issue
4
Pages
1122-1131
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W2014830732
Cited by
336
References
40
Citations by year
2025: 7 · 2024: 4 · 2023: 9 · 2022: 10 · 2021: 7 · 2020: 8 · 2019: 16 · 2018: 11 · 2017: 15 · 2016: 21 · 2015: 20 · 2014: 18 · 2013: 22 · 2012: 29
FWCI
14.50
Type
journal article
Language
en
Open access
closed
Locations
  • Arthritis & Rheumatism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
  • Health Sciences › Medicine › Hematology › Autoimmune and Inflammatory Disorders Research
  • Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
Keywords
rheumatoid arthritis, joint damage progression, synovium, cytokine mRNA expression, IL-1β, TNF-α, IL-17, IL-10, interferon-gamma, disease duration, synovial biopsy, predictive biomarkers
MeSH terms
Adult, Aged, Aged, 80 and over, Arthritis, Rheumatoid, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Prognosis, Prospective Studies, RNA, Messenger, Synovial Membrane, Time Factors, Cytokines, Disease Progression

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review